Tanman, Ü.; Derici, M.K.; Türktaş, M.; Cansaran-Duman, D.
Comprehensive Evaluation of Usnic Acid as a Potential Drug Candidate for Triple-Negative Breast Cancer: Insights from Transcriptomic, Proteomic, and In Vivo Analyses. Molecules 2025, 30, 4281.
https://doi.org/10.3390/molecules30214281
AMA Style
Tanman Ü, Derici MK, Türktaş M, Cansaran-Duman D.
Comprehensive Evaluation of Usnic Acid as a Potential Drug Candidate for Triple-Negative Breast Cancer: Insights from Transcriptomic, Proteomic, and In Vivo Analyses. Molecules. 2025; 30(21):4281.
https://doi.org/10.3390/molecules30214281
Chicago/Turabian Style
Tanman, Ümmügülsüm, Mehmet Kürşat Derici, Mine Türktaş, and Demet Cansaran-Duman.
2025. "Comprehensive Evaluation of Usnic Acid as a Potential Drug Candidate for Triple-Negative Breast Cancer: Insights from Transcriptomic, Proteomic, and In Vivo Analyses" Molecules 30, no. 21: 4281.
https://doi.org/10.3390/molecules30214281
APA Style
Tanman, Ü., Derici, M. K., Türktaş, M., & Cansaran-Duman, D.
(2025). Comprehensive Evaluation of Usnic Acid as a Potential Drug Candidate for Triple-Negative Breast Cancer: Insights from Transcriptomic, Proteomic, and In Vivo Analyses. Molecules, 30(21), 4281.
https://doi.org/10.3390/molecules30214281